Estradiol Gel
FDA Label NDC 69238-2452

48 label sections · Submitted to the FDA by Amneal Pharmaceuticals Ny Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Ny Llc for the product Estradiol (NDC 69238-2452). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: endometrial cancer with unopposed estrogen in women with a uterus, 2.1 important use information, 2.2 treatment of moderate to severe vasomotor symptoms due to menopause, 3 dosage forms and strengths, 4 contraindications, 5.1 cardiovascular disorders, 5.2 malignant neoplasms, 5.3 risks associated with the co-administration of estrogen plus progestogen, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.